The story of Viagra presents a complex picture for investors. While the initial launch generated substantial returns, the end of its exclusive rights opened the floodgates to off-brand versions, dramatically https://cyrusfqhj391482.sharebyblog.com/41685659/the-copyright-and-pharma-a-risky-bet